Cornerstone Capital Management Holdings’s Keryx Biopharmaceuticals Inc KERX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2017
Q4
$192K Buy
+41,500
New +$192K ﹤0.01% 1119
2015
Q2
Sell
-4,700
Closed -$60K 1522
2015
Q1
$60K Hold
4,700
﹤0.01% 1302
2014
Q4
$67K Sell
4,700
-11,600
-71% -$165K ﹤0.01% 1197
2014
Q3
$224K Buy
16,300
+4,100
+34% +$56.3K ﹤0.01% 1088
2014
Q2
$187K Buy
+12,200
New +$187K ﹤0.01% 1116
2013
Q4
Sell
-15,600
Closed -$157K 1366
2013
Q3
$157K Sell
15,600
-800
-5% -$8.05K ﹤0.01% 1085
2013
Q2
$123K Buy
+16,400
New +$123K ﹤0.01% 1100